Composition
- Active ingredients
- BRIMONIDINE TARTRATE EQ 0.33% BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA204708.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Mirvaso
- Active substance
- brimonidine tartrate
- Route
- Topical
- Dosage form
- Gel
- Applicant
- Galderma Labs LP
- Status
- Prescription
- FDA approval
- 23 Aug 2013
- Application
- NDA204708-001